We aimed to compare dosimetric characteristics of conventional linear accerator-based treatment plans to those created using the robotic CyberKnife ® (CK) treatment planning system for patients with early-stage lung cancer. Eight early-stage lung cancer patients treated with stereotactic body radiotherapy (SBRT) using a conventional linac-based (LIN) system were included in this study. New treatment plans were created for the patients with the CK treatment planning system in order to compare the two platforms' dosimetric characteristics.
Introduction
Radiotherapy has had an important role in the treatment of early-stage non-small-cell lung cancer (NSCLC) patients, albeit with disappointing results. On the other hand, many early-stage patients were potentially resectable but medically inoperable, in which case the local control rates dropped to 20% to 50% with conventional radiotherapy (1-3). With the advances in technology, three-dimensional conformal techniques have been used to increase the tumor dose without increasing normal tissue toxicity and these have reported better local control and survival rates (4-6), but still not comparable with Technology in Cancer Research & Treatment, Volume 11, Number 3, June 2012 surgery. Several investigators used stereotactic body radiotherapy (SBRT) for medically inoperable early-stage NSCLC patients and reported excellent results with local control rates ranging between 80% to 90% with limited toxicities to normal tissues (7) (8) (9) (10) (11) (12) .
SBRT, delivered with both conventional linac-based (LIN) systems and the robotic CyberKnife ® system (CK) (Accuray Incorporated, Sunnyvale, CA) (13). Even though these modalities have very different characteristics and dose distributions, only few reports have been published to compare the dosimetric differences between two methods (14) (15) (16) . Additionally, there are no guidelines for patient selection between these two modalities.
Our department has been equipped with both a Varian Trilogy (Varian, Inc., Milpitas, CA) and a CK system for SBRT since November 2009 and treatment method selection has depended on the mutual decision of the physician and the patient. Patient tolerance to long fraction times, risks of fiducial placement, or the localization of tumor have been the main factors for patient selection. In this article; we aim to compare the dosimetric characteristics of SBRT plans obtained with the LIN and CK systems in patients with early-stage lung cancer.
Materials and Method
Eight early-stage, medically inoperable, NSCLC patients who were treated previously with the Trilogy system were chosen for this dosimetric study. According to our departmental SBRT protocol, all patients were immobilized with a vacuum mattress in supine position with both arms raised, using a T-shaped holding bar. Planning computed tomographies (CT) (Flash ® , Siemens Heathcare, Erlagen, Germany) were obtained in three different respiratory phases: free breathing, full expiration, and full inhalation; with 1.25 mm slice thickness without any breathing restraint such as abdominal belt, stereotactic body frame or respiratory gating. None of these patients had fiducial markers. These three different CT scans were then transferred into the LIN treatment planning system (Eclipse TM 8.6, Varian) and the free-breathing CT was also transferred into the CK-based planning system (Multiplan).
For each patient, we created three different LIN and CK SBRT plans. Treatment planning was performed using the free-breathing CTs. A dose of 54 Gy in three fractions (3 3 18 Gy) was prescribed to cover at least 95% of defined PTVs for both the CK and LIN plans. Lung inhomogenity corrections were used for both of the treatment planning systems.
For LIN SBRT image guidance, we used pre-treatment online kV-kV images and cone-beam CT (CBCT) scans, along with post-treatment CBCT scans for treatment verification.
Conventional Linac-Based (LIN) Treatment Planning
Following the CT study, the gross tumor volume (GTV) was delineated by a radiation oncologist using the lung CT window settings (window width 1500 Hounsfield Units (HU) and window level 2500 HU) in all three CT scans in different phases. The three GTVs were then added together in the cine vision mode for definition of the internal target volume (ITV) for each patient treated with the LIN system. For set-up uncertainty, a uniform safety margin of 5 mm was added to create the PTV. The same radiation oncologist also delineated the organs at risk (OARs), which were lung, spinal cord, esophagus, and heart, on the free-breathing-respiratoryphase CT. A five-field three-dimensional (3D) coplanar (5F), a seven-field 3D coplanar (7F), and a dynamic conformal arc plan (ARC) were generated for each patient to deliver highly conformal prescription dose distributions. Beam arrangement was primarily based on our department's experience and custom-designed according to the localization of the tumor and to minimize doses to OARs. For all plans, 6-MV output was used, but when necessary, 18-MV photon energy was also used in maximum two fields of five-and seven-field plans. According to the location of the tumor, arc plans angled between 150 and 340 degrees. Whenever required, computer-optimized collimator rotations were used. All plans were non-opposing and coplanar; the dose was prescribed to isodose lines ranging from 75% to 86%.
Cyberknife (CK) Treatment Planning
The free-breathing CT images and previously delineated structures of these patients were retrospectively transferred to CK planning system and a PTV was created by adding a 5-mm margin to the GTV. Plans were performed on MultiPlan ® Treatment Planning System (Accuray). In order to have a uniform coverage of the PTV and acceptable treatment duration, one or two collimators were used and the collimator size was chosen between 40%-70% of the maximum dimension of the PTV. Conformal optimization technique was used and the prescription isodose line included 100% of the PTV and was generally between 75%-86% isodose lines.
Comparison Parameters
The prescription dose constraints were previously defined in details in different RTOG protocols (RTOG protocols 0236, 0618, 0813, and 0915 [http://www.rtog.org/members/active. html#lung]). Even though these trials were designed basicly for linear accelerator based treatments, we used the same parameters for both systems to make a direct comparison. The dose was prescribed to an isodose line that allowed 95% PTV coverage. Maximum dose within the PTV was defined as D max . For the evaluation of dosimetric parameters of each plan, four criteria were defined: volume encompassed by the 54-Gy isodose surface (cc) 5 V54; volume encompassed by the 27-Gy isodose surface (cc) 5 V27; conformity index 54 Gy (CI 54 ): the ratio of V54 to PTV (CI 54 5 V54/PTV); and conformity index 27 Gy (CI 27 ): the ratio of 50% isodose surface volume to PTV (CI 27 5 V27/PTV); this ratio is also defined as intermediate dose spillage. Volumes of the lung receiving 5, 10, 15, and 20 Gy or more (V5, V10, V15, V20) were calculated for each plan.
The plans were compared according to PTV volumes, D max , V54, V27, CI 54 , CI 27 , and lung volumes (V5, V10, V15, V20). The difference between dosimetric variables was evaluated with nonparametric related Friedman test and Wilcoxon test, with 0.05 or less accepted as statistically significant.
Results
Between November 2009 and December 2010, 19 stage I lung cancer patients referred to our clinic for stereotactic body radiotherapy with CK. Of these 19 patients, eight were treated with LIN and 11 with CK SBRT.
The eight patients treated with LIN SBRT were not suitable for gold marker replacement or Xsight ® lung tracking system (Accuray). Three patients had poor pulmonary function, in two patients the tumor was too small for Xsight lung tracking and fiducial replacement was not successful technically, and three patients refused the fiducial placement procedure because of the risk of pneumothorax.
Patients' characteristics are listed in Table I . All patients had peripherally located T1-2N0M0 NSCLC. The volume of the GTV ranged between 0.8-13.1 cc (median 4.3) for all patients. PTV for CK plans ranged between 6-37 cc (median 15.8), and PTV for LIN plans ranged between 9.8-71.6 cc (median 29.1). PTV volumes were significantly higher for LIN plans (p , 0.012).
Dosimetric Parameters for Target Volumes
Both LIN and CK plans provided satisfactory dose coverage, D95 (the dose received by 95% of PTV) values was miminum 54 Gy and identical for all plans, whereas maximum dose within PTV (D max ) was significantly lower in conformal Arc plans when compared with other plans, including CK plans (p 5 0.01) (Table II) . Figure 1 shows the V54 values in each patient's case, which is the volume of the isodose shell that provides PTV coverage of 95%. Among all plans, CK had significantly the tightest isodose shell which received 54 Gy (p 5 0.0001) due to its small PTV size, but when LIN were compared with each other, Arc plans were better than others (p 5 0.03). Similar results were obtained when V27 was compared for all plans, CK V27 was significantly smaller (p 5 0.001), however there was no difference among linac plans' V27.
The conformity index ratios (CI 54 and CI 27 ) were shown in Table III . CK plans' CI 54 and CI 27 were higher than other plans, among linac plans, the arc plan was the better for CI. For CK plans CI 54 was over 1.2, which should be kept lower to minimize normal tissues' receiving high doses.
No statistically significant difference was observed for lung volumes (V5, V10, V15, and V20) for all plans.
Discussion
Stereotactic body radiotherapy (SBRT) for early stage NSCLC is defined as high-dose, highly conformal, and precisely targeted treatments with fewer fractions than conventional radiotherapy. The terminology and the description of patients who can potentially benefit from this technique were evaluated by the ASTRO Emerging Technology Committee (13). Even though some guidelines exist about treatment planning and dosimetry for SBRT for lung cancer, there are still some unclear areas on the differences between planning methodology and methods used (13, 17, 18) . There is also not much data on the comparison of different planning systems. This is probably due to availability of only one type of stereotactic radiotherapy platforms in most departments.
In this study, we aimed to compare dosimetric features of the same patients' data for the two different SBRT methods available at our center.
Selection of patients for a particular SBRT method is an important issue. While some patients with good performance status may tolerate long treatment times, fiducial implantation, and breath-hold techniques, some others may not. At this point, it is important to select patients for different methods and try to select the best method they would benefit from. None of our study patients were eligible for CK SBRT, even though this dedicated SBRT unit with its high accuracy and real time respiratory tumor tracking capability is available at our center (19). In order to treat this group of patients, we defined our LIN protocol by the guidance of previous reports (12-14, 18, 20) and treated them thereafter. We compared the dosimetric differences between the two systems. The longterm follow-up of these patients treated with the LIN protocol will be reported later.
The major problem of SBRT for lung is the tumor motion due to breathing. The management of respiratory motion was documented in detail by AAPM Task Force Group 76 (21). Briefly, if the magnitude of motion is greater than 5 mm, or significant normal tissue sparing can be gained, an extra effort of using respiratory management techniques is recommended. Similarly, The ROSEL protocol distinguished several techniques to avoid unnecessary exposure of OAR and recommended that one might use any of these or a combination thereof (18). Within the ROSEL protocol, 4DCT was highly recommended, but because of its rare use, as a replacement, multiple (at least three) rapid planning CT scans were also allowed. Due to the absence of 4DCT, we used three different respiratory-phase CT scans. The advantage of this approach over the slow CT is Abbreviations: PTV 5 Planning target volume, LIN 5 Conventional linac based plans, CK 5 Cyberknife, 5F 5 Fivefield three-dimensional (3D) coplanar, 7F 5 Seven-field 3D coplanar, ARC 5 Dynamic conformal arc plan. the blurring caused by the motion during freebreathing is significantly reduced (21). In the study by Fukumoto et al., (22) inoperable stage I lung patients were treated with image-guided radiotherapy (IGRT) without the need for breath control; plans were created by CT scans taken at three respiratory phases; and the prescription dose was 48-60 Gy in eight fractions.
One-year survival and local control rates were 94% and 71%, respectively. Similar to our study, this study has shown that SBRT delivers a high dose of radiation to the target volume and minimizes the dose to normal tissue with high survival and local control rates (22).
In RTOG 0236 study (12), a total dose of 60 Gy in three fractions was used without heterogeneity corrections. Based on the studies of Timmerman et al. (11, 23) , when heterogeneity correction was used, this dose corresponded to a total dose of 54 Gy in three fractions. The results of RTOG 236 showed a high rate of primary tumor control (97.6% at three years) with a median overall survival rate of 55.8% at three years. RTOG has started a new trial, RTOG 0813, to determine the safe and effective doses for centrally located lung tumors; and another, RTOG 0915, is in progress to refine the dose of SBRT in peripheral lung tumors and the relationship between the primary tumor control rate and observations on pre-and post-SBRT hypoxia markers. These trials will provide further information about the optimum dose and fractionation schemes in the future.
There are very significant differences in the technical aspects of different SBRT platforms in planning and delivery, which make it a challenge to compare the results across different planning systems, as these technical factors clearly influence the dose heterogenity and doses at OARs, and thus, may impact both primary tumor control and toxicity of SBRT. In our study, we aimed to eliminate some of the selection bias due to variations in patient anatomy and delineation of PTV and OARs, using images and contour sets belonging to a single cohort.
Comparing the two sets of treatment plans in terms of PTV's was questionable, because of ITV definition in LIN planning, which was certain to result in larger PTVs. The use of an ITV margin is inevitable when 4DCT or multiphase CT is used, but for CK treatments, ITV is not necessary as this system has an automated image guidance subsystem, which continuously points the robot-mounted linear accelerator at the target as it moves with uninhibited respiration during radiation delivery. Wang et al. have previously reported a dosimetric comparison of 4DCT and multiphase CT images in SBRT planning for lung cancer (24). They found that conventional CT PTVs had 42.5% and multiphase CT PTVs 24.6% larger volumes than 4DCT volumes, but when compared in terms of PTV coverage, multiphase CT PTVs provided excellent coverage of 4DCT PTVs. The authors concluded that multiphase CT scans can be used as an alternative to 4DCT, if that modality is not available. Our results agree this study (24) with bigger PTVs in LIN plans than those obtained with CK plans.
In our study, PTV volumes were significantly smaller in CK plans compared to the LIN SBRT plans due to the respiratory tracking capability. CK plans had superior dosimetric findings compared to LIN plans in terms of V54 and V27. Among LIN plans, V54 was significantly smaller in ARC plans; but no difference was observed for V27 values. On the other hand, LIN plans have a better plan quality (CI 27 and CI 54 ) than CK. Conformity index for CK was even unacceptable for some of our plans when compared with the RTOG protocols. Inherently, PTV volumes were significantly larger in LIN plans when compared to CK plans.
Recently a study from University of Texas has compared the dosimetric characteristics of robotic and LIN SBRT for lung cancer (14) . Similarly to our study, they retrospectively planned eight patients treated with LIN system then simulated CK plans and compared the resulting plans with each other. The major difference from our study was the use of 4DCT and abdominal compression with 4D dose calculation. In this study, target dose coverage and normal tissue doses were identical for both plans, but the dose to GTV was more heterogeneous for CK than for LIN plans. Our findings were similar to these results; we observed that PTV dose homogeneity (D max ) was better in ARC plans. The authors also mentioned that the location of the GTV was important in terms of high doses to the normal lung. CK plans for anteriorly located tumors resulted in lower doses to normal lung than LIN plans, whereas for posteriorly located tumors, CK plans resulted in higher doses to normal lung. They explained these observations by the characteristics of the robotic treatment, as it cannot be delivered from underneath the patient; therefore, with posteriorly located tumors, V20 was higher than anteriorly located tumors, but all of them were still within limits. The tumor location would probably be one of the most important factors to evaluate between two systems; however we could not show a significant difference due to location, this was probably because of the variety of localition for this small cohort.
In this study, we have evaluated V20, V15, V10 and V5 for lung. As V20 is a value defined for conventional fractionation, there is still no data for hypofractionation for the risk of pneumonitis. Both in our study and in the previous study by Ding et al. (14) , the lung doses were not high enough to produce probable lung complications for both modalities.
The lack of gating with 4DCT, to minimize the amount of normal lugs treated, was the major limitation of this study, however most of the developing countries with limited sources, does not have all the new technical improvements in their hospitals. This study is important to show that linacbased SBRT with three phased CT and ITV margin has comparable dosimetric results with CyberKnife SBRT. Target volume in expiration, inspiration and free-breathing for LIN SBRT to determine which phase of the respiration is optimal for normal lung sparing may be another topic to study where gating is available.
Our study demonstrated important dosimetric differences between two SBRT methods. However, these differences between the two methods in terms of dosimetry, have questionable clinical significance in practice. CK is a dedicated unit for SBRT, smaller PTV volumes and real-time tumor tracking are the major advantages over linac based SBRT. On the other hand, there are advantages of LIN treatments with no necessity for fiducial markers, which may cause pneumothorax. Treatment time is significantly shorter for linac plans (20-30 min) compared to CK plans (60-90 min) in this study, however the length of treatment time will be similar if gating was used. On the other hand, one should keep in mind that use of respiratory gating methods, micro MLC and IMRT, and VMAT techniques may lead to better dosimetric quality in LIN plans. Both CK and LIN methods are reasonable for lung SBRT with clinically unsignificant dosimetric differences. The clinicians should evaluate patient and tumor related circumstances to choose whether LIN or CK may be better.
